These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 27271340)

  • 1. Advanced Glycation End Product (AGE) Accumulation in the Skin is Associated with Depression: The Maastricht Study.
    van Dooren FE; Pouwer F; Schalkwijk CG; Sep SJ; Stehouwer CD; Henry RM; Dagnelie PC; Schaper NC; van der Kallen CJ; Koster A; Denollet J; Verhey FR; Schram MT
    Depress Anxiety; 2017 Jan; 34(1):59-67. PubMed ID: 27271340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.
    Hartog JW; Hummel YM; Voors AA; Schalkwijk CG; Miyata T; Huisman RM; Smit AJ; Van Veldhuisen DJ
    J Card Fail; 2008 Sep; 14(7):596-602. PubMed ID: 18722326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between dietary and skin advanced glycation end products: the Rotterdam Study.
    Chen J; Waqas K; Tan RC; Voortman T; Ikram MA; Nijsten TEC; de Groot LCPGM; Uitterlinden AG; Zillikens MC
    Am J Clin Nutr; 2020 Jul; 112(1):129-137. PubMed ID: 32453418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
    Scheijen JLJM; Hanssen NMJ; van Greevenbroek MM; Van der Kallen CJ; Feskens EJM; Stehouwer CDA; Schalkwijk CG
    Clin Nutr; 2018 Jun; 37(3):919-925. PubMed ID: 29381139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.
    Hanssen NM; Engelen L; Ferreira I; Scheijen JL; Huijberts MS; van Greevenbroek MM; van der Kallen CJ; Dekker JM; Nijpels G; Stehouwer CD; Schalkwijk CG
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1369-73. PubMed ID: 23780372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma advanced glycation end-products and skin autofluorescence are increased in COPD.
    Gopal P; Reynaert NL; Scheijen JL; Engelen L; Schalkwijk CG; Franssen FM; Wouters EF; Rutten EP
    Eur Respir J; 2014 Feb; 43(2):430-8. PubMed ID: 23645408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin Autofluorescence and Pentosidine Are Associated With Aortic Stiffening: The Maastricht Study.
    van Eupen MG; Schram MT; van Sloten TT; Scheijen J; Sep SJ; van der Kallen CJ; Dagnelie PC; Koster A; Schaper N; Henry RM; Kroon AA; Smit AJ; Stehouwer CD; Schalkwijk CG
    Hypertension; 2016 Oct; 68(4):956-63. PubMed ID: 27550921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum advanced glycation endproducts are associated with left ventricular dysfunction in normal glucose metabolism but not in type 2 diabetes: The Hoorn Study.
    Linssen PB; Henry RM; Schalkwijk CG; Dekker JM; Nijpels G; Brunner-La Rocca HP; Stehouwer CD
    Diab Vasc Dis Res; 2016 Jul; 13(4):278-85. PubMed ID: 27190078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study.
    Bijnen M; van Greevenbroek MMJ; van der Kallen CJH; Scheijen JL; van de Waarenburg MPH; Stehouwer CDA; Wouters K; Schalkwijk CG
    J Diabetes Res; 2019; 2019():6289831. PubMed ID: 31218233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.
    Beisswenger PJ; Howell S; Mackenzie T; Corstjens H; Muizzuddin N; Matsui MS
    Diabetes Technol Ther; 2012 Mar; 14(3):285-92. PubMed ID: 22023375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.
    Sánchez E; Betriu À; Yeramian A; Fernández E; Purroy F; Sánchez-de-la-Torre M; Pamplona R; Miquel E; Kerkeni M; Hernández C; Simó R; Lecube A; ; ; Hernández M; Rius F; Polanco D; Barbé F; Torres G; Suárez G; Portero-Otin M; Jové M; Colàs-Campàs L; Benabdelhak I; Farràs C; Ortega M; Manuel Valdivielso J; Bermúdez-López M; Martínez-Alonso M
    J Atheroscler Thromb; 2019 Oct; 26(10):879-889. PubMed ID: 30842389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen.
    Cefalu WT; Bell-Farrow AD; Wang ZQ; Sonntag WE; Fu MX; Baynes JW; Thorpe SR
    J Gerontol A Biol Sci Med Sci; 1995 Nov; 50(6):B337-41. PubMed ID: 7583789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study.
    Martens RJH; Broers NJH; Canaud B; Christiaans MHL; Cornelis T; Gauly A; Hermans MMH; Konings CJAM; van der Sande FM; Scheijen JLJM; Stifft F; Wirtz JJJM; Kooman JP; Schalkwijk CG
    PLoS One; 2019; 14(8):e0221058. PubMed ID: 31408493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple non-invasive assessment of advanced glycation endproduct accumulation.
    Meerwaldt R; Graaff R; Oomen PHN; Links TP; Jager JJ; Alderson NL; Thorpe SR; Baynes JW; Gans ROB; Smit AJ
    Diabetologia; 2004 Jul; 47(7):1324-1330. PubMed ID: 15243705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Habitual intake of dietary advanced glycation end products is not associated with generalized microvascular function-the Maastricht Study.
    Linkens AMA; Houben AJHM; Kroon AA; Schram MT; Berendschot TTJM; Webers CAB; van Greevenbroek M; Henry RMA; de Galan B; Stehouwer CDA; Eussen SJMP; Schalkwijk CG
    Am J Clin Nutr; 2022 Feb; 115(2):444-455. PubMed ID: 34581759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification.
    van Eupen MG; Schram MT; Colhoun HM; Scheijen JL; Stehouwer CD; Schalkwijk CG
    Cardiovasc Diabetol; 2013 Oct; 12():149. PubMed ID: 24134530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between advanced glycation end products and ocular circulation in type 2 diabetes.
    Hashimoto K; Kunikata H; Yasuda M; Ito A; Aizawa N; Sawada S; Kondo K; Satake C; Takano Y; Nishiguchi KM; Katagiri H; Nakazawa T
    J Diabetes Complications; 2016; 30(7):1371-7. PubMed ID: 27209548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients.
    Nur E; Brandjes DP; Schnog JJ; Otten HM; Fijnvandraat K; Schalkwijk CG; Biemond BJ;
    Br J Haematol; 2010 Oct; 151(1):62-9. PubMed ID: 20678158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
    Fokkens BT; Mulder DJ; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    PLoS One; 2017; 12(3):e0173379. PubMed ID: 28264049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end-products in anterior chamber aqueous of cataractous patients.
    Franke S; Stein F; Dawczynski J; Blum M; Kubetschka U; Stein G; Strobel J
    J Cataract Refract Surg; 2003 Feb; 29(2):329-35. PubMed ID: 12648645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.